The purpose of this project is to determine the neuropsychological deficits most characteristics of patients in the earliest stages of Alzheimer's disease (AD) or who are at risk for AD. A secondary but related aim is to determine whether the rate or pattern of cognitive decline differs as a function of the age of disease onset. Since the two greatest risk factors for AD are old age and familial aggregation two groups at increased risk for AD are the very old and first degree relatives of AD patients. Both groups are available for this project. Patients in the following groups will be evaluated every six months: cognitively normal elderly, elderly persons with cognitive decline but who do not meet NINCDS criteria for AD, early AD, AD, first degree relatives of AD patients. Serial tests will assess aspects of memory, language, praxis, psychomotor speed, and verbal I.Q. It is hypothesized that delayed recall memory tests and measures of psychomotor speed will best differentiate early AD and high risk persons and their discriminating power may be greater when corrected for verbal I.Q. All participants except the first degree relatives will be enrolled in an autopsy program and will provide neuropathologic and neurochemical data for correlative studies. Acute phase reactants, a potential biologic marker of early AD will be measured in all groups and will be available for correlative studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG002219-20
Application #
6299221
Study Section
Project Start
2000-04-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
20
Fiscal Year
2000
Total Cost
$423,960
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545
Toker, Lilah; Mancarci, Burak Ogan; Tripathy, Shreejoy et al. (2018) Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia. Biol Psychiatry 84:787-796
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Bryois, Julien; Garrett, Melanie E; Song, Lingyun et al. (2018) Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat Commun 9:3121
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302

Showing the most recent 10 out of 306 publications